
It is believed that the two local candidates — which are in early stages of human trials — will enter the market with a lag of a few weeks as compared to the Oxford candidate.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34bAccT
via
IFTTT
0 comments:
Post a Comment